Villaluz, Rey D.
HRN: 25-69-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2024
METRONIDAZOLE 500MG (TAB)
08/17/2024
08/26/2024
PO
500mg
Q8
Hepatic Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes